GLP 1
The Oral GLP-1 Pills Coming Soon: Orforglipron, Amycretin, and VK2735 Compared
The era of the weight-loss pill has arrived, and three names lead the next wave: orforglipron (already approved), amycretin, and VK2735 (both investigational). All…
Is Orforglipron FDA Approved Yet? Timeline and What to Expect
Yes. Orforglipron was approved by the FDA on April 1, 2026, and is sold under the brand name Foundayo. It’s approved for adults with…
Orforglipron Side Effects: What Early Studies Report
Orforglipron, now FDA approved and sold as Foundayo, has a side-effect profile that looks a lot like injectable GLP-1 drugs despite being a pill:…
Bimagrumab and GLP-1s: The Drug Studied to Preserve Muscle During Weight Loss
Bimagrumab is an unusual entry in the weight-loss world: it’s not a GLP-1 drug at all, but an antibody being studied to solve one…
What Is Mazdutide? The GLP-1/Glucagon Drug from Lilly and Innovent
Mazdutide is a weekly weight-loss injection that’s notable for a milestone: it’s the world’s first approved drug to combine GLP-1 and glucagon activity in…
What Is Efpeglenatide? A Once-Weekly GLP-1 With Heart-Protection Data
Efpeglenatide is a once-weekly GLP-1 medication that stands out for one big reason: it’s backed by a major clinical trial showing it reduces the…
What Is Pemvidutide? The GLP-1/Glucagon Drug for Obesity and Fatty Liver
Pemvidutide is an investigational weight-loss and liver drug that hits two hormone targets at once: GLP-1 (which curbs appetite) and glucagon (which increases energy…
Talking to Your Partner About Body and Intimacy Changes on GLP-1s
Losing a significant amount of weight changes more than your body, it changes the dynamics of your closest relationship, and talking openly with your…
GLP-1 Medications and the Vaginal Microbiome: What Emerging Research Shows
Researchers are only beginning to map how weight and weight loss affect the vaginal microbiome, and the early picture suggests a real but complex…
